A diagnostic blood test for prion diseases
In this issue of Blood, Thomas et al1 report on their comparative analysis of 3 highly specific blood assays to detect transmissible spongiform encephalopa
Related Articles
Longitudinal detection of prion infection in preclinical sheep blood samples compared using 3 assays
Key PointsThree blood tests detected prion infection in sheep blood samples up to 26 months before the onset of clinical signs, with 100% specificity.The t
FDA red and green lights: October 2024
October’s US approvals included Scemblix, Vyloy and Itovebi, while Lumakras was delayed.
My Gut Feeling – Stomach Cancer Foundation of Canada
My Gut Feeling is the Stomach Cancer Foundation of Canada. We are a stomach cancer support network for patients, survivors and caregivers and we provide peer-to-peer…
Prognostic Value of Minimal Residual Disease (MRD) Among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation
AbstractBackground: Autologous stem cell transplantation (ASCT) can be curative for a subset of patients (pts) with relapsed/refractory classical Hodgkin l
Signposts | Andrea L Merrill — Intima
SIGNPOSTS | Andrea L. Merrill My phone vibrates next to me on the scratchy motel sheets. It’s still dark outside as I rouse myself from…
Leukemic myeloblasts with erythrophagocytosis
An 80-year-old woman was diagnosed with acute myeloid leukemia (AML). Bone marrow aspirate revealed increased large-sized myeloblasts with scant cytoplasm, irregular nuclei, and fine chromatin.…
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
Key Points. ctDNA is as an easily accessible source of tumor DNA for cHL genotyping.ctDNA is a radiation-free tool to track residual disease in cHL.
Moderators of Intervention Efficacy in the Pathways to Wellness Trial of Survivorship Education and Mindfulness Meditation for Younger Breast Cancer Survivors | JCO Oncology Practice
PURPOSEDepression is associated with poor outcomes in breast cancer survivors (BCSs), with higher prevalence among younger women. The Pathways to Wellness (PTW; ClinicalTrials.gov identifier: NCT03025139)…
